Ketogenic diets therapy in the management of epileptic spasms syndrome

Area of Science:

• Neurology
• Pediatrics
• Metabolic Therapies

Background:

• Infantile Epileptic Spasm Syndrome (IESS) presents in early infancy with various causes, often leading to refractory epilepsy and intellectual disability.
• Current pharmacological treatments for IESS have limitations, necessitating exploration of alternative therapeutic strategies.
• Ketogenic diet therapy (KDT) is a recognized non-pharmacologic intervention for medically refractory epilepsy.

Purpose of the Study:

• To review recent advancements in Ketogenic Diet Therapy (KDT) for treating Infantile Epileptic Spasm Syndrome (IESS).
• To discuss the various types, mechanisms, and expanding applications of KDT in neurological disorders.
• To identify factors influencing KDT efficacy and outline future research directions for IESS management.

Main Methods:

• Literature review of recent scientific evidence on KDT for IESS.
• Analysis of studies evaluating KDT efficacy, safety, and tolerability.
• Exploration of KDT mechanisms and influencing factors.

Main Results:

• Recent evidence supports the efficacy, safety, and tolerability of KDT in treating IESS.
• KDT demonstrates significant reductions in seizure frequency in infants with IESS.
• KDT also shows potential for improving cognitive function and long-term prognosis in affected children.

Conclusions:

• Ketogenic diet therapy is an effective non-pharmacologic treatment for medically refractory IESS.
• KDT offers benefits beyond seizure control, including cognitive improvements.
• Further research into KDT applications and influencing factors is warranted for optimizing neurological disorder treatments.